BlackRock, Inc. 13D and 13G filings for Lexeo Therapeutics, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-17 6:13 pm Purchase | 2025-09-30 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | BlackRock Inc. BLK | 2,168,444 4.000% | 346,478 (+19.02%) | Filing |
| 2025-02-04 3:45 pm Purchase | 2024-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | BlackRock Inc. BLK | 1,821,966 5.500% | 1,821,966 (New Position) | Filing |